Introduction: Needless to say that correct and real-time detection and effective prognosis of the COVID-19 are necessary to deliver the best possible care for patients and, accordingly, diminish the pressure on the healthcare industries. Hence our paper aims to present an intelligent algorithm for selecting the best features from the dataset and developing Machine Learning(ML) based models to predict the COVID-19 and finally opted for the best-performing algorithm. Methods: In this developmental study, the clinical data of 1703 COVID-19 and non-COVID-19 patients Using a single-center registry from February 9, 2020, to December 20, 2020, were used. The Minimum Redundancy Maximum Relevance (mRMR) feature selection algorithm identified the most relevant variables. Then, chosen features feed into the several data mining methods, including K-Nearest Neighbors, AdaBoost Classifier, Decision Tree, HistGradient Boosting Classifier, and Support Vector Machine. A 10-fold cross-validation method and six performance evaluation metrics were used to evaluate and compare these implemented algorithms, and finally, the best model was implemented. Results: Out of the 34 included features, 11 variables were selected as the essential features. The results of using ML algorithms indicated that the best performance belongs to the AdaBoost classifier with mean accuracy = 92.9%, mean specificity = 89.3%, mean sensitivity = 94.2%, mean F-measure = 91.6 %, mean KAPA = 94.3% and mean ROC = 92.1 %. Conclusion: The empirical results reveal that the Adaboost model yielded higher performance than other classification models and developed our Clinical Decision Support Systems (CDSS) interface to discriminate positive COVID-19 from negative cases.

No abstract

No abstract

No abstract

An outbreak of atypical pneumonia termed coronavirus disease 2019 (COVID-19) has spread worldwide since the beginning of 2020. It poses a significant threat to the global health and the economy. Physicians face ambiguity in their decision-making for COVID-19 diagnosis and treatment. In this respect, designing an intelligent system for early diagnosis of the disease is critical for mitigating virus spread and resource optimization. This study aimed to establish an artificial neural network (ANNs)-based clinical model to diagnose COVID-19. The retrospective dataset used in this study consisted of 400 COVID-19 case records (250 positives vs. 150 negatives) and 18 columns for the diagnostic features. The backpropagation technique was used to train a neural network. After designing multiple neural network configurations, the area under the receiver-operating characteristic curve (AUC), accuracy, sensitivity, and specificity values were calculated to measure the model performance. The two nested loops architecture of 9-10-15-2 (10 and 15 neurons used in layer one and layer two, respectively) with the ROC of 98.2%, sensitivity of 96.4%, specificity of 90.6%, and accuracy of 94 % were introduced as the best configuration model for COVID-19 diagnosis. ANN is valuable as a decision-support tool for clinicians to improve the COVID-19 diagnosis. It is promising to implement the ANN model to improve the accuracy and speed of the COVID-19 diagnosis for timely screening, treatment, and careful monitoring. Further studies are warranted for verifying and improving the current ANN model.

No abstract

Background: The novel 2019 Coronavirus disease (COVID-19) poses a great threat to global public health and the economy. The earlier detection of COVID-19 is the key to its treatment and mitigating the transmission of the virus. Given that Machine Learning (ML) could be potentially useful in COVID-19 identification, we compared 7 decision tree (DT) algorithms to select the best clinical diagnostic model. Methods: A hospital-based retrospective dataset was used to train the selected DT algorithms. The performance of DT models was measured using performance criteria, such as accuracy, sensitivity, specificity, receiver operating characteristic (ROC), and precision-recall curves (PRC). Finally, the best decision model was obtained based on comparing the mentioned performance criteria. Results: Based on the Gini Index (GI) scoring model, 13 diagnostic criteria, including the lung lesion existence (GI= 0217), fever (GI= 0.205), history of contact with suspected people (GI= 0.188), O 2 saturation rate in the blood (GI= 0.181), rhinorrhea (GI= 0.177), dyspnea (GI = 0.177), cough (GI = 0.159), history of taking the immunosuppressive drug (GI= 0.145), history of respiratory failure (ARDS) (GI= 0.141), lung lesion situation (GI= 0.133) and appearance (GI= 0.126), diarrhea (GI= 0.112), and nausea and vomiting (GI = 0.092) have been obtained as the most important criteria in diagnosing COVID-19. The results indicated that the J-48, with the accuracy= 0.85, F-Score= 0.85, ROC= 0.926, and PRC= 0.93, had the best performance for diagnosing COVID-19. Conclusion: According to the empirical results, it is promising to implement J-48 in health care settings to increase the accuracy and speed of COVID-19 diagnosis.

Introduction: Predicting acute respiratory insufficiency due to coronavirus disease 2019 (COVID-19) can diminish the severe complications and mortality associated with the disease. This study aimed to develop an intelligent system based on machine learning (ML) models for frontline clinicians to effectively triage high-risk patients and prioritize who needs mechanical intubation (MI). Materials and Methods: In this retrospective-design study, the data regarding 482 COVID-19 hospitalized patients from February 9, 2020, to July 20, 2021, was analyzed by six ML classifiers. The most critical clinical variables were identified by a minimal-redundancy-maximal-relevance (mRMR) feature selection technique. In the next step, the models' performance was assessed using confusion matrix criteria and, finally, the best model was adopted. Results: Proposed models were implemented using 23 confirmed variables. Results of comparing six selected ML algorithms indicated the extreme gradient boosting (XGBoost) classifier with 84.7% accuracy, 76.5 % specificity, 90.7% sensitivity, 85.1% f-measure, 87.4% Kappa statistic, and 85.3% for receiver operating characteristic (ROC) had the best performance in the intubation prediction. Conclusion: It is found that ML enables a satisfactory accuracy level in calculating intubation risk in COVID-19 patients. Therefore, using the ML-based intelligent models, notably the XGBoost algorithm, actually enables recognizing high-risk cases and advising correct therapeutic and supportive care by the clinicians.